000 | 01014 a2200277 4500 | ||
---|---|---|---|
005 | 20250514200502.0 | ||
264 | 0 | _c20040916 | |
008 | 200409s 0 0 eng d | ||
022 | _a0921-4410 | ||
024 | 7 |
_a10.1016/s0921-4410(03)21023-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAiba, Keisuke | |
245 | 0 | 0 |
_aUpper gastrointestinal tumors. _h[electronic resource] |
260 |
_bCancer chemotherapy and biological response modifiers _c2003 |
||
300 |
_a485-508 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xclassification |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aSalvage Therapy |
650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
700 | 1 | _aOgawa, Makoto | |
773 | 0 |
_tCancer chemotherapy and biological response modifiers _gvol. 21 _gp. 485-508 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0921-4410(03)21023-1 _zAvailable from publisher's website |
999 |
_c15035971 _d15035971 |